Lisa Maher

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 23

Top Venues

Addiction (Abingdon, England)

Drug and alcohol review

Behavioral medicine (Washington, D.C.)

Journal of the International AIDS Society

National Health and Medical Research Council

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Health and Medical Research Council

Australia

Senior Research Fellow

UNSW Sydney

Australia

Professor & Program Head :: Faculty of Medicine, Kirby Institute

Burnet Institute

Australia

Honorary Senior Principal Research Fellow

Publications

Daniela K van Santen, Sara Lodi, Paul Dietze, Wijnand van den Boom, Kanna Hayashi PhD, Huiru Dong, Zishan Cui, Lisa Maher, Matthew Hickman, Anders Boyd, Maria Prins
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials. Addiction (Abingdon, England) (2023)
Daniela K van Santen, Sara Lodi, Paul Dietze, Wijnand van den Boom, Kanna Hayashi PhD, Huiru Dong, Zishan Cui, Lisa Maher, Matthew Hickman, Anders Boyd, Maria Prins
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: a pooled analysis of emulated trials. Addiction (Abingdon, England) (2023)
Daniela K van Santen, Sara Lodi, Paul Dietze, Wijnand van den Boom, Kanna Hayashi PhD, Huiru Dong, Zishan Cui, Lisa Maher, Matthew Hickman, Anders Boyd, Maria Prins
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials. Addiction (Abingdon, England) (2023)
Daniela K van Santen, Sara Lodi, Paul Dietze, Wijnand van den Boom, Kanna Hayashi PhD, Huiru Dong, Zishan Cui, Lisa Maher, Matthew Hickman, Anders Boyd, Maria Prins
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials. Addiction (Abingdon, England) (2023)
Kasun Rathnayake, Paul A Agius, Bernadette Ward, Matthew Hickman, Lisa Maher, Mark Stoové, Joseph S Doyle, Margaret Hellard, Anna Wilkinson, Brendan Quinn, Sione Crawford, Keith Sutton, Paul Dietze
The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia. Addiction (Abingdon, England) (2023)
Steven P Philpot, Garrett E Prestage, Martin Holt, Lisa Maher, Bridget Gabrielle Haire, Adam Bourne, Mohamed Ahmed Hammoud
Reasons for not Using HIV Pre-Exposure Prophylaxis (PrEP) among Gay and Bisexual Men in Australia: Mixed-Methods Analyses from a National, Online, Observational Study. Behavioral medicine (Washington, D.C.) (2022)
Jenny Iversen, Handan Wand, Hamish McManus, Gregory J Dore, Lisa Maher
Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post- unrestricted availability of direct acting antiviral therapies. Addiction (Abingdon, England) (2022)
Jenny Iversen, Handan Wand, Po-Lin Chan, Linh-Vi Le, Lisa Maher
Systematic Review of Hepatitis C Virus Prevalence in the WHO Western Pacific Region. Viruses 14 (7) (2022)
Penelope L Hill, Mark Stoové, Paul A Agius, Lisa Maher, Matthew Hickman, Sione Crawford, Paul Dietze
Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study. Addiction (Abingdon, England) 117 (12) (2022)
Jenny Iversen, Handan Wand, Hamish McManus, Gregory J Dore, Lisa Maher
Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies. Addiction (Abingdon, England) (2022)
Jenny Iversen, Amy Peacock, Olivia Price, Jude Byrne, Melissa A Jackson, Lisa Maher
COVID-19 vaccination among people who inject drugs: Leaving no one behind. Drug and alcohol review 40 (4) (2021)
Daniela K van Santen, Anders Boyd, Amy Matser, Lisa Maher, Matthew Hickman, Sara Lodi, Maria Prins
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial. Addiction (Abingdon, England) 116 (11) (2021)
Jenny Iversen, Keith Sabin, Judy Chang, Ruth Morgan Thomas, Garrett Prestage, Steffanie A Strathdee, Lisa Maher
COVID-19, HIV and key populations: cross-cutting issues and the need for population-specific responses. Journal of the International AIDS Society 23 (10) (2020)
Jenny Iversen, Lisa Maher
Commentary on Hamilton White et al. : Receptive syringe-sharing among people who inject drugs in rural settings. Addiction (Abingdon, England) 116 (2) (2020)
Lisa Maher, Jenny Iversen, Louise Geddes
Mapping out a research agenda on alcohol and other drug stigma: Commentary on Seear. Drug and alcohol review 39 (2) (2020)
Louise Geddes, Jenny Iversen, Handan Wand, Lisa Maher
Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia. Addiction (Abingdon, England) 116 (3) (2020)
Anna Y Palmer, Peter Higgs, Nick Scott, Paul A Agius, Lisa Maher, Paul M Dietze
Prevalence and correlates of simultaneous, multiple substance injection (co-injection) among people who inject drugs in Melbourne, Australia. Addiction (Abingdon, England) 116 (4) (2020)
Sedona Sweeney, Zoe Ward, Lucy Platt, Lorna Guinness, Matthew Hickman, Vivian D Hope, Lisa Maher, Jenny Iversen, Sharon J Hutchinson, Josie Smith, Rachel Ayres, Ingrid Hainey, Peter Vickerman
Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs. Addiction (Abingdon, England) 114 (3) (2019)
Lisa Maher, Joanne Neale
Adding quality to quantity in randomized controlled trials of addiction prevention and treatment: a new framework to facilitate the integration of qualitative research. Addiction (Abingdon, England) 114 (12) (2019)
Zoe Ward, Lucy Platt, Sedona Sweeney, Vivian D Hope, Lisa Maher, Sharon Hutchinson, Norah E Palmateer, Josie Smith, Noel Craine, Avril Taylor, Natasha Martin, Rachel Ayres, John Dillon, Matthew Hickman, Peter Vickerman
Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets? Addiction (Abingdon, England) (2018)
Katinka van de Ven, Lisa Maher, Handan Wand, Sonja Memedovic, Eva Jackson, Jenny Iversen
Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia. Drug and alcohol review 37 (7) (2018)
Lisa Maher, George Christopher Dertadian
Qualitative research. Addiction (Abingdon, England) 113 (1) (2017)
Lucy Platt, Silvia Minozzi, Jennifer Reed, Peter Vickerman, Holly Hagan, Clare French, Ashly Jordan, Louisa Degenhardt, Vivian D Hope, Sharon Hutchinson, Lisa Maher, Norah E Palmateer, Avril Taylor, Julie Bruneau, Matthew Hickman
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Addiction (Abingdon, England) 113 (3) (2017)

Lisa Maher.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lisa Maher